TNE provides comprehensive energy saving solutions using turbo technology. TNE’s air foil bearing designs are patented in the US. TNE air bearing high-speed turbo blowers are compact, affordable, robust, and eco-friendly features with high efficiency, TNE offers wide ranges of product lines from 10 hp to 400 hp for single core turbo blowers. Also, TNE offers multi-core turbo blower system for wide ranges of flow modulation without dead zone of operation.
THPharm Corp.
THPharm Corp. is dedicated to developing improved and innovative therapeutics through a capital-efficient 505(b)(2) pathway. Leveraging deep expertise in formulation development, clinical execution, and patent strategy, we aim to accelerate commercialization, address unmet market needs, and enhance patients’ quality of life. THPharm Corp. is an innovative bio-pharmaceutical company focused on metabolic diseases, including diabetes, obesity, and hypertension. We are dedicated to developing patient-friendly oral and buccal drug delivery therapies that improve treatment adherence and deliver better clinical outcomes in real-world practice. Core Projects 1. Hypertension in Patients with Diabetes Mellitus (Type 2) THPharm’s lead pipeline is a once-daily fixed-dose combination (FDC) oral therapy currently in global Phase 3 clinical trials in Korea and Thailand. Designed as a compact and easy-to-take tablet, it enables the management of two of the most common comorbidities in metabolic disease with a single product, helping reduce patients’ daily medication burden and improve adherence. In parallel, we are also preparing indication expansion into cardiovascular diseases, particularly heart failure (HF), supported by AI-integrated development strategies. 2. Oral and Buccal-Targeted Obesity Therapy THPharm is developing the world’s first buccal-delivered therapy containing GLP-1 RA. Unlike currently available injectable therapies, this thin sheet or patch formulation delivers the drug directly through the oral mucosa, offering a needle-free, convenient, and adherence-friendly alternative. Beyond obesity, we are expanding development into obesity-related comorbidities, including metabolic dysfunction-associated steatohepatitis (MASH/NAFLD) and diseases involving the liver, pancreas, and cardiovascular system. 3. Next-Generation DDS Platform Beyond individual product development, THPharm is advancing a proprietary drug delivery platform that integrates Drug-Loaded Filament (DLF), Bio-Ink, and Bio-Printing technologies. This platform enables the development of novel oral and buccal dosage forms, personalized or combination therapies, and scalable GMP manufacturing infrastructure for global markets.
SturgeonBio
Sturgeon Bio: Pioneering Bio-Pharmaceutical Solutions through Advanced Life Science Sturgeon Bio is a specialized biotechnology company dedicated to the research and development of high-purity bio-active materials derived from sturgeons. Bridging the gap between nature and science, we focus on producing premium raw materials for the pharmaceutical and dermo-cosmetic industries. Through our proprietary extraction and purification technologies, we ensure the highest standards of efficacy and safety. At Sturgeon Bio, we are committed to delivering innovative health solutions globally, guided by our philosophy of benefiting humanity through bio-innovation.
META BIOMED Co., LTD
Since its foundation in 1990 as a manufacturer of medical devices aimed at contributing to the development of the health and medical industry, META-BIOMED CO., LTD. has produced excellent products, including biodegradable surgical sutures, dental products and medical devices, through sustained R&D. The company exports its products to over 80 countries, including the USA and Europe with branch offices in China, Germany, US and Vietnam.
KOREA Biohealth Hub
KOREA Biohealth Hub is a collaborative booth with eight key organizations shaping Korea’s pharmaceutical and biotech landscape. Click here for a one-pager on each organization. 1. CARM (Council For Advanced Regenerative Medicine) 2. KBIOHealth (OSONG Medical Innovation Foundation) 3. KFRM (Korean Fund for Regenerative Medicine) 4. KHIDI (Korea Health Industry Development Institute) 5. KIT (Korea Institute of Toxicology) 6. KMEDIhub (Daegu-Gyeongbuk Medical Innovation Foundation) 7. KoBIA (Korea Biomedicine Industry Association) 8. KPBMA (Korea Pharmaceutical and Bio-Pharma Manufacturers Association)
Hyundaibioland
Hyundai Bioland, Korea’s no.1 company in natural materials, is engaged in bio-business in the areas of cosmetics, nutraceuticals, and regenerative medicine based on world-class quality and technology. Our business provides environment-friendly, safe bio-solutions for healthy and beautiful lives. Through differentiated technologies and creative challenges, Hyundai Bioland will grow as a company that creates an abundant life for all.